Hemofiltration for Contrast-Induced Nephropathy

September 7, 2005 updated by: Nara Medical University

Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Japan
    • Nara
      • Kashihara, Nara, Japan, 634-8522
        • Recruiting
        • First Dept of InternalMedicine, Nara Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min

Exclusion Criteria:

  • Emergent cardiac catheterization
  • Patients on chronic dialysis
  • Patients with HYHA>III heart failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures

Outcome Measure
Need for hemodialysis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nara Medical University

Investigators

  • Study Director: Yoshihiko Saito, MD, PhD, Nara Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

September 7, 2005

First Submitted That Met QC Criteria

September 7, 2005

First Posted (Estimate)

September 12, 2005

Study Record Updates

Last Update Posted (Estimate)

September 12, 2005

Last Update Submitted That Met QC Criteria

September 7, 2005

Last Verified

September 1, 2005

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K0001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe